– The cost of hepatitis C treatment varies according on the type of medicine used. However, the price range for an 8- to 12-week course is $54,000 to $95,000 (or higher). A 12-week prescription of Zepatier, for instance, can cost up to $54,600, while a 12-week course of Harvoni can cost up to $94,500.
How much does the Hep C medication cost?
Modern medicines for hepatitis C virus are a game-changer. Oral direct-acting antivirals (DAAs) were released in 2011 and are efficacious, work within a few weeks or months, and do not cause significant adverse effects. However, they come at a hefty cost.
- According to a 2018 research, a single tablet of one hepatitis C medication costs $1,000.
- The entire cost of its 12-week course of therapy was $84,000.
- Another medication cost $23,600 monthly.
- This is for therapy that might last six to twelve months.
- Obviously, you will not pay the whole price if your health insurance covers your prescription.
However, not all DAAs are covered by insurance. And your co-payments may be substantial. Whether or whether you have insurance, you may be eligible for assistance to reduce your out-of-pocket costs.
Does insurance cover hepatitis C medications?
However, hepatitis C treatment is often covered by insurance. Thus, insurance will be the most cost-effective option for many individuals. You may still be subject to limitations, such as prior permission or step treatment, in order to obtain your desired prescription.
Antiviral medications for hepatitis C are highly effective, but expensive. Just one Sovaldi medication costs $1,000. A 12-week treatment session with this medication costs $84,000. Other hepatitis C medicines are likewise expensive: A 12-week therapy with Harvoni costs $94,500.12-week therapy with Mavyret costs $39,600.
Zepatier therapy costs $54,600 for 12 weeks Treatment with Technivie costs $76,653 for 12 weeks. Drugs for hepatitis C are expensive due to their great demand and the high price of bringing them to market. Developing a new treatment, testing it in clinical trials, and selling it can cost almost $900 million for pharmaceutical corporations.
The absence of a national health care system to negotiate prescription rates on behalf of customers also contributes to the high cost. Also, there is limited rivalry from other pharmaceutical businesses. Consequently, hepatitis C medicine producers may charge practically whatever they want.